Stay updated on ARGX-113 Safety & Efficacy in Pemphigus Clinical Trial
Sign up to get notified when there's something new on the ARGX-113 Safety & Efficacy in Pemphigus Clinical Trial page.

Latest updates to the ARGX-113 Safety & Efficacy in Pemphigus Clinical Trial page
- Check5 days agoNo Change Detected
- Check12 days agoNo Change Detected
- Check19 days agoChange DetectedThe study page now displays a 403 Forbidden error instead of the study record content. This indicates restricted access to the page, with the usual trial details replaced by an error message.SummaryDifference17%

- Check40 days agoChange DetectedA new line noting the 2017 U.S. NIH Grant/Contract was added to the study identifiers, and the page revision was updated from v3.6.5 to v3.6.6.SummaryDifference0.1%

- Check61 days agoChange DetectedThe page now displays the new revision label v3.6.5, replacing the prior v3.6.4. This indicates a minor update to the page’s revision history without changing the study information shown.SummaryDifference0.1%

- Check75 days agoChange DetectedRevision updated from v3.6.3 to v3.6.4, representing a minor metadata/version update to the page rather than a substantive change to study details.SummaryDifference0.1%

- Check97 days agoChange DetectedRevision v3.6.3 has been added and v3.6.2 removed. This reflects a minor update to the page's revision history rather than study content.SummaryDifference0.1%

- Check104 days agoChange DetectedRevision updated from v3.6.0 to v3.6.2 in the page footer, signaling a newer revision of the page. It does not change visible content or functionality.SummaryDifference0.1%

Stay in the know with updates to ARGX-113 Safety & Efficacy in Pemphigus Clinical Trial
Enter your email address, and we'll notify you when there's something new on the ARGX-113 Safety & Efficacy in Pemphigus Clinical Trial page.